The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...
Evolucumab (Repatha) and alirocumab (Praluent) are injectable monoclonal antibodies. They have been joined by inclisiran ...
Researchers are studying a new approach to HDFN prevention to reduce cases in countries where incidence rates remain high.
Lonza Group AG has selected Bank of America Corp. and Centerview Partners to arrange the sale of its capsules and health ...
Biopharmaceutical CMO Market Rapid outsourcing trends and robust investments in advanced manufacturing drive the biopharmaceutical CMO mark ...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
News Medical on MSN1d
Lecanemab and donanemab slow Alzheimer’s decline, but is the benefit worth the cost?Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...
Astria advances innovative therapies for hereditary angioedema and atopic dermatitis. Strong cash position supports pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback